Interface Biologics, Inc. raised $7M Series B venture round, led by BDC Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$8M
Top Valuation
-
Interface Biologics, Inc. raised $7M in a Series B round.
The round was announced on 01/10/11.
The round was led by BDC Capital.